Literature DB >> 8968217

Myasthenia gravis: immunological mechanisms and immunotherapy.

R A Lewis1, J F Selwa, R P Lisak.   

Abstract

This review of the immunological aspects of myasthenia gravis and the immunotherapy of the disease emphasizes the current state of knowledge of the immunological events at the neuromuscular junction, and the immunoregulatory abnormalities noted in myasthenic patients. The treatment modalities available to the clinician are discussed in an attempt to provide information that will allow for a rational approach to therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8968217     DOI: 10.1002/ana.410370707

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

2.  Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports.

Authors:  Mi Jeong Park; Yun A Kim; Shin Seok Lee; Byeong Chae Kim; Myeong Kyu Kim; Ki Hyun Cho
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

3.  Myasthenia Gravis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.972

4.  Preoperative high-dose steroid has long-term beneficial effects for myasthenia gravis.

Authors:  Syuichi Tetsuka; Ken-Ichi Fujimoto; Kunihiko Ikeguchi
Journal:  Neurol Res Int       Date:  2013-07-14

5.  FK506 attenuates thymic output in patients with myasthenia gravis.

Authors:  Takao Mitsui; Yukiko Kuroda; Shu-Ichi Ueno; Naoko Matsui; Ryuji Kaji
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

6.  Characterization of patients with ocular myasthenia gravis - A case series.

Authors:  Arnon Karni; Ali Asmail; Vivian E Drory; Hadar Kolb; Anat Kesler
Journal:  eNeurologicalSci       Date:  2016-04-25

7.  Risk of incident autoimmune diseases in patients with thymectomy.

Authors:  Tzu-Min Lin; Yu-Sheng Chang; Tsung-Yun Hou; Hui-Ching Hsu; Sheng-Hung Lin; Wei-Sheng Chen; Pei-I Kuo; Yi-Chun Lin; Jin-Hua Chen; Chi-Ching Chang
Journal:  Ann Clin Transl Neurol       Date:  2020-06-01       Impact factor: 4.511

8.  The Epidemiology of Myasthenia Gravis in Korea.

Authors:  Hyung Seok Lee; Hye Sun Lee; Ha Young Shin; Young Chul Choi; Seung Min Kim
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.